# OnCo record cd30 (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/cd30/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "cd30" ;
  schema:name "CD30"@en ;
  schema:description "CD30 is a protein on the malignant Reed-Sternberg cells of Hodgkin lymphoma and on some T-cell lymphomas, and the address for the ADC brentuximab vedotin."@en ;
  schema:url <https://onco.cc/targets/cd30/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/CD30>, <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:11923>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000120949>, <https://www.uniprot.org/uniprotkb/P28908/entry>, <https://www.ncbi.nlm.nih.gov/gene/943> ;
  owl:sameAs <http://www.wikidata.org/entity/Q3648608> ;
  schema:citation <https://en.wikipedia.org/wiki/CD30>, <https://doi.org/10.1038/nrc2542>, <https://doi.org/10.1073/pnas.91.23.10962>, <https://doi.org/10.1056/NEJMoa0905680>, <https://doi.org/10.1038/nrc1452> ;
  onco:tag "adc-target" ;
  schema:alternateName "TNFRSF8" ;
  onco:targetClass "surface-antigen" ;
  onco:firstDescribed "1992"^^xsd:gYear ;
  onco:related <https://onco.cc/biomarkers/cd30-expression/> ;
  onco:cancers <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/brentuximab-vedotin/>, <https://onco.cc/drugs/eb-car30-nk/> ;
  onco:pathways <https://onco.cc/pathways/tumor-microenvironment/>, <https://onco.cc/pathways/antigen-presentation-immunoediting/>, <https://onco.cc/pathways/myeloid-suppression-axis/>, <https://onco.cc/pathways/oncogenic-viruses/>, <https://onco.cc/pathways/inflammation-nfkb/> .